A deadline is coming up on May 3, 2016 in the lawsuit filed for certain investors in NASDAQ:RMTI shares over alleged securities laws violations by Rockwell Medical Inc .
Investors who purchased shares of Rockwell Medical Inc (NASDAQ:RMTI) have certain options and there are strict and short deadlines running. Deadline: May 3, 2016. NASDAQ:RMTI stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The plaintiff alleges on behalf of purchasers of Rockwell Medical Inc (NASDAQ:RMTI) that the defendants issued false and misleading statements to investors and/or failed to disclose thatthe primary product offering for Triferic will be in a powder packet packaging, which the FDA has not yet approved, that Rockwell Medical is seeking to obtain transitional add-on payment reimbursement for Triferic with the Centers for Medicare & Medicaid Services instead of bundled reimbursement, and that as a result, defendants’ statements about Rockwell Medical’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
On September 9, 2015, Rockwell Medical Inc announced the U.S. commercial launch of Triferic, a FDA approved iron product indicated to replace iron and maintain hemoglobin in hemodialysis patients in the United States. Then on February 29, 2016, Rockwell Medical Inc’s CFO Tom Klema disclosed to investors on a conference call after the market closed that sales of Triferic were “immaterial” for 2015. Shares of Rockwell Medical Inc (NASDAQ:RMTI) declined on March 2, 2016, to as low as $5.80 per share.
On April 26, 2016, NASDAQ:RMTI shares closed at $9.71 per share.
Those who purchased NASDAQ:RMTI shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
Leave Your Comments